Axsome Therapeutics, Inc. (AXSM) stock
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Axsome Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Axsome Therapeutics's enterprise value was $7.67B on Nov 11, 2026, against $7.48B a year earlier. Over the last 5 years it ranged from $936.69M to $12.47B, with a median of $3.95B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.67B | -15.2% |
| 2025 | Dec 31, 2025 | $9.05B | +129.1% |
| 2024 | Dec 31, 2024 | $3.95B | +12.0% |
| 2023 | Dec 29, 2023 | $3.53B | +9.7% |
| 2022 | Dec 30, 2022 | $3.22B | +136.7% |
| 2021 | Dec 31, 2021 | $1.36B | -53.0% |
| 2020 | Dec 31, 2020 | $2.89B | -18.5% |
| 2019 | Dec 31, 2019 | $3.54B | +5176.8% |
| 2018 | Dec 31, 2018 | $67.12M | -39.5% |
| 2017 | Dec 29, 2017 | $110.95M | +16.3% |
| 2016 | Dec 30, 2016 | $95.40M | +16.7% |
| 2015 | Dec 31, 2015 | $81.73M | – |
See a number that looks wrong?